Sarafidis Kosmas, Chotas William, Agakidou Eleni, Karagianni Paraskevi, Drossou Vasiliki
1st Department of Neonatology and Neonatal Intensive Care, School of Medicine, Aristotle University of Thessaloniki, Ippokrateion General Hospital, 54642 Thessaloniki, Greece.
Department of Neonatology, University of Vermont, Burlington, VT 05405, USA.
Children (Basel). 2021 Oct 2;8(10):883. doi: 10.3390/children8100883.
Defining improvements in healthcare can be challenging due to the need to assess multiple outcomes and measures. In neonates, although progress in respiratory support has been a key factor in improving survival, the same degree of improvement has not been documented in certain outcomes, such as bronchopulmonary dysplasia. By exploring the evolution of neonatal respiratory care over the last 60 years, this review highlights not only the scientific advances that occurred with the application of invasive mechanical ventilation but also the weakness of the existing knowledge. The contributing role of non-invasive ventilation and less-invasive surfactant administration methods as well as of certain pharmacological therapies is also discussed. Moreover, we analyze the cost-benefit of neonatal care-respiratory support and present future challenges and perspectives.
由于需要评估多种结果和指标,定义医疗保健方面的改善可能具有挑战性。在新生儿中,尽管呼吸支持方面的进展是提高存活率的关键因素,但在某些结果(如支气管肺发育不良)方面,尚未有同等程度的改善记录。通过探讨过去60年新生儿呼吸护理的演变,本综述不仅强调了有创机械通气应用所带来的科学进步,也指出了现有知识的不足之处。还讨论了无创通气、侵入性较小的表面活性剂给药方法以及某些药物治疗的作用。此外,我们分析了新生儿护理呼吸支持的成本效益,并提出了未来的挑战和前景。